Home > M&A deals 2018 > Aisling Capital invests in Atreca, Inc.
PIPE · Life Science · January 2018

Aisling Capital invests in Atreca, Inc.

On January 1, 2018, Aisling Capital invested in Atreca, Inc., a life science company in California, United States.

Deal at a glance

AnnouncedJanuary 1, 2018 TypePIPE TargetAtreca, Inc. Buyer Aisling Capital SectorLife Science LocationCalifornia, United States ValueNot disclosed

Target company

Atreca, Inc.
California, United States
Life Sciencesector
1992founded
Activestatus
View the company profile →

Buyer

Aisling Capital
Private equity firm · 88 deals on record
  • 30th transaction in life science
  • 39th transaction in United States
88deals, all time
65in this sector
2020latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Atreca, Inc.?Aisling Capital invested in Atreca, Inc. on January 1, 2018.

What type of deal was it?It was a pipe in the life science sector in 2018.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).